Related references
Note: Only part of the references are listed.Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors
Rajendar K. Mittapalli et al.
CANCER RESEARCH (2017)
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Simona Bramante et al.
ONCOIMMUNOLOGY (2016)
Adeno-associated virus (AAV) vectors in cancer gene therapy
Jorge L. Santiago-Ortiz et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
De-Gang Song et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
LV305, a dendritic cell-targeting integration-deficient ZVex™-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response
Tina Chang Albershardt et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Down-regulating HIF-1 by lentivirus-mediated shRNA for therapy of triple negative breast cancer
Shuang Li et al.
CANCER BIOLOGY & THERAPY (2015)
Adeno-associated virus-mediated cancer gene therapy: Current status
Jingfeng Luo et al.
CANCER LETTERS (2015)
Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors
M. Trepel et al.
GENE THERAPY (2015)
Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases
Yuefeng Yang et al.
HUMAN GENE THERAPY (2015)
Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response
Katharina M. Uhlig et al.
JOURNAL OF VIROLOGY (2015)
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
J. Knezevic et al.
ONCOGENE (2015)
Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells
Xianqi Zhao et al.
VIRUSES-BASEL (2015)
Inhibitory and Apoptosis-Inducing Effects of Newcastle Disease Virus Strain AF2240 on Mammary Carcinoma Cell Line
Umar Ahmad et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Antitumor Activity of Lentivirus-mediated Interleukin-12 Gene Modified Dendritic Cells in Human Lung Cancer in Vitro
Hassan Abdellah Ahmed Ali et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth
Samina Alam et al.
CANCER BIOLOGY & THERAPY (2014)
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
William Wold et al.
CURRENT GENE THERAPY (2014)
Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II plus Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo
Severine Cire et al.
PLOS ONE (2014)
Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models
Bo-Rim Yi et al.
STEM CELL RESEARCH (2014)
Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
Wei Zhu et al.
CANCER BIOLOGY & THERAPY (2013)
Sustained production of a soluble IGF-I receptor by gutless adenovirus-transduced host cells protects from tumor growth in the liver
N. Wang et al.
CANCER GENE THERAPY (2013)
Combining virotherapy and angiotherapy for the treatment of breast cancer
M. Bazan-Peregrino et al.
CANCER GENE THERAPY (2013)
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors
Don G. Morris et al.
INVESTIGATIONAL NEW DRUGS (2013)
Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
Margaret Gil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors
Jordi Martinez-Quintanilla et al.
STEM CELLS (2013)
Lentiviral vectors: basic to translational
Toshie Sakuma et al.
BIOCHEMICAL JOURNAL (2012)
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
T. T. Sahin et al.
CANCER GENE THERAPY (2012)
Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host
Z. Zhang et al.
CANCER GENE THERAPY (2012)
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Dmitriy Zamarin et al.
FUTURE MICROBIOLOGY (2012)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo
Wei Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
Kelley A. Parato et al.
MOLECULAR THERAPY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Human Neural Stem Cell Tropism to Metastatic Breast Cancer
Donghong Zhao et al.
STEM CELLS (2012)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
Martijn P. Lolkema et al.
CLINICAL CANCER RESEARCH (2011)
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
Mahsa Mohebtash et al.
CLINICAL CANCER RESEARCH (2011)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer
I. V. Subramanian et al.
GENE THERAPY (2011)
Requirements for baculoviruses for clinical gene therapy applications
Hanna P. Lesch et al.
JOURNAL OF INVERTEBRATE PATHOLOGY (2011)
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
Xi Xia et al.
MOLECULAR CANCER (2011)
Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer
J. J. Cody et al.
CANCER GENE THERAPY (2010)
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
James L. Gulley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells
Tomoyuki Suzuki et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
Zachary C. Hartman et al.
CLINICAL CANCER RESEARCH (2010)
Intravenous administration of ReolysinA®, a live replication competent RNA virus is safe in patients with advanced solid tumors
Radharani Gollamudi et al.
INVESTIGATIONAL NEW DRUGS (2010)
Recombinant Baculovirus as a Highly Potent Vector for Gene Therapy of Human Colorectal Carcinoma: Molecular Cloning, Expression, and In Vitro Characterization
Arghya Paul et al.
MOLECULAR BIOTECHNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies
Carlos Almeida Ramos et al.
STEM CELLS (2010)
Possible DNA Viral Factors of Human Breast Cancer
Chun-Ru Hsu et al.
Cancers (2010)
Lentivirus-Mediated Small Interfering RNA Targeting VEGF-C Inhibited Tumor Lymphangiogenesis and Growth in Breast Carcinoma
Baoliang Guo et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells
Michael Fasullo et al.
CELL CYCLE (2009)
Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
Erica M. Gomes et al.
CLINICAL CANCER RESEARCH (2009)
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
Ravi A. Madan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
J. R. Tysome et al.
GENE THERAPY (2009)
Oncolytic adenoviruses targeted to cancer stem cells
Joshua J. Short et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Human Neural Stem Cells Can Target and Deliver Therapeutic Genes to Breast Cancer Brain Metastases
Kyeung Min Joo et al.
MOLECULAR THERAPY (2009)
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
Candice Willmon et al.
MOLECULAR THERAPY (2009)
Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries
Stefan Michelfelder et al.
PLOS ONE (2009)
Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
Ninette Amariglio et al.
PLOS MEDICINE (2009)
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
David H. Kirn et al.
NATURE REVIEWS CANCER (2009)
Cancer, stem cells, and oncolytic viruses
Camilla Ribacka et al.
ANNALS OF MEDICINE (2008)
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling
Ling Qiao et al.
CANCER LETTERS (2008)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: Applications for cancer gene therapy
Akihiro Nawa et al.
CURRENT GENE THERAPY (2008)
Oncolytic virus therapy using genetically engineered herpes simplex viruses
Tomoki Todo
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Gene therapy progress and prospects cancer: oncolytic viruses
T-C Liu et al.
GENE THERAPY (2008)
Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages
Hidde J. Haisma et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
Zhili Xu et al.
JOURNAL OF VIROLOGY (2008)
Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector
K. L. Laurie et al.
GENE THERAPY (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma
Mariam A. Stoff-Khalili et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M. Arlen et al.
JOURNAL OF UROLOGY (2007)
Conditionally replicating adenoviruses for cancer treatment
Youssef Jounaidi et al.
CURRENT CANCER DRUG TARGETS (2007)
PANVAC™-VF:: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma
Ravi A. Madan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Herpes simplex virus 1 (HSV-1) for cancer treatment
Y. Shen et al.
CANCER GENE THERAPY (2006)
Adeno-associated virus vectors: potential applications for cancer gene therapy
CW Li et al.
CANCER GENE THERAPY (2005)
Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine
JH Kim et al.
HUMAN GENE THERAPY (2005)
Transcriptionally targeted adenovirus vectors
H Sadeghi et al.
CURRENT GENE THERAPY (2005)
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory
V Schirrmacher
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Multiple costimulatory modalities enhance CTL avidity
JW Hodge et al.
JOURNAL OF IMMUNOLOGY (2005)
Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector
D Xu et al.
MOLECULAR THERAPY (2005)
Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells
G Lizée et al.
HUMAN GENE THERAPY (2004)
Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development
P Gonin et al.
GENE THERAPY (2004)
Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells
T Moreau et al.
MOLECULAR THERAPY (2004)
Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy
AS Lalani et al.
MOLECULAR THERAPY (2004)
Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer
A Nakao et al.
ANNALS OF ONCOLOGY (2004)
Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy for liver cancer
L Wang et al.
GASTROENTEROLOGY (2004)
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10
O Teshigahara et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Viral and non-viral vectors in gene therapy: Technology development and clinical trials
K Lundstrom et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2003)
Long-term expression of angiostatin suppresses metastatic liver cancer in mice
R Xu et al.
HEPATOLOGY (2003)
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene
G Marodon et al.
BLOOD (2003)
Delivering antisense telomerase RNA by a hybrid adenovirus/adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells
XW Zhang et al.
ONCOGENE (2003)
Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice
H Takakuwa et al.
ARCHIVES OF VIROLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo
WY Shi et al.
CANCER GENE THERAPY (2002)
Reovirus oncolysis of human breast cancer
KL Norman et al.
HUMAN GENE THERAPY (2002)
Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice
S Gyorffy et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: A role for combined anti-angiogenesis and immunotherapy
S Gyorffy et al.
JOURNAL OF IMMUNOLOGY (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors
WD Xiao et al.
MOLECULAR THERAPY (2000)
Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer
SM Scholl et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Share Paper
